Actinium Seeks to Disrupt As Radioligand Candidate Succeeds In Pivotal Pre-Transplant AML Trial

 
• By Ayisha Sharma
  
Sign for Radioactivity
Radioligands Combine A Tumor-Targeting Molecule With A Radioactive Atom • Source: Shutterstock

More from Clinical Trials

More from R&D